omeprazole has been researched along with Cough in 40 studies
Omeprazole: A 4-methoxy-3,5-dimethylpyridyl, 5-methoxybenzimidazole derivative of timoprazole that is used in the therapy of STOMACH ULCERS and ZOLLINGER-ELLISON SYNDROME. The drug inhibits an H(+)-K(+)-EXCHANGING ATPASE which is found in GASTRIC PARIETAL CELLS.
omeprazole : A racemate comprising equimolar amounts of (R)- and (S)-omeprazole.
5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole : A member of the class of benzimidazoles that is 1H-benzimidazole which is substituted by a [4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl group at position 2 and a methoxy group at position 5.
Cough: A sudden, audible expulsion of air from the lungs through a partially closed glottis, preceded by inhalation. It is a protective response that serves to clear the trachea, bronchi, and/or lungs of irritants and secretions, or to prevent aspiration of foreign materials into the lungs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty-five participants were randomised (23 to omeprazole, 22 to placebo), with 40 (20 in each group) having cough monitoring before and after treatment." | 9.30 | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. ( Dutta, P; Forbes, R; Forrest, IA; Funston, W; Griffin, SM; Jones, R; Mossop, H; Pearson, J; Ryan, V; Sen, S; Simpson, AJ; Smith, JA; Ward, C, 2019) |
| "Out of 45 patients referred for unexplained chronic persistent cough, 36 had at least one of the GI investigations (endoscopy, 24-h esophageal pH-metry and a 4-week trial of proton pump inhibitor (PPI) therapy) positive and were randomly assigned to receive either 30 mg lansoprazole o." | 9.12 | Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. ( Baldi, F; Cappiello, R; Cavoli, C; Ghersi, S; Roda, E; Torresan, F, 2006) |
| "To evaluate the efficacy and safety of baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough (GERC) unresponsive to standard anti-reflux therapy." | 7.79 | Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. ( Chen, Q; Liang, SW; Lv, HJ; Qiu, ZM; Xu, XH; Yang, ZM; Yu, L, 2013) |
| "To report a case of chronic, persistent cough induced by omeprazole therapy." | 7.72 | Omeprazole-induced intractable cough. ( Delafosse, C; Howaizi, M, 2003) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 7.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| "Twenty-one patients completed both treatment periods." | 6.69 | Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. ( Hietanen, EK; Kiljander, TO; Salomaa, ER; Terho, EO, 2000) |
| "Twenty-three patients were evaluated for gastroesophageal reflux disease; six (26%) were eventually determined to have an acid-related cough." | 6.69 | A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. ( Kavuru, MS; Ours, TM; Richter, JE; Schilz, RJ, 1999) |
| "Forty-five participants were randomised (23 to omeprazole, 22 to placebo), with 40 (20 in each group) having cough monitoring before and after treatment." | 5.30 | Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis. ( Dutta, P; Forbes, R; Forrest, IA; Funston, W; Griffin, SM; Jones, R; Mossop, H; Pearson, J; Ryan, V; Sen, S; Simpson, AJ; Smith, JA; Ward, C, 2019) |
| "In infants with a clinical presentation suggestive of chronic GER-related cough, the use of omeprazole and bethanacol appears to be viable therapeutic option." | 5.16 | [A pilot trial on the treatment of gastroesophageal reflux-related cough in infants]. ( Adamko, DJ; Jones, AB; Majaesic, CM; Skappak, C, 2012) |
| "Out of 45 patients referred for unexplained chronic persistent cough, 36 had at least one of the GI investigations (endoscopy, 24-h esophageal pH-metry and a 4-week trial of proton pump inhibitor (PPI) therapy) positive and were randomly assigned to receive either 30 mg lansoprazole o." | 5.12 | Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole. ( Baldi, F; Cappiello, R; Cavoli, C; Ghersi, S; Roda, E; Torresan, F, 2006) |
| "Clinical symptoms, cough symptom score, capsaicin cough sensitivity, gastroesophageal reflux diagnostic questionnaire (GerdQ) score, findings of multichannel intraluminal impedance-pH monitoring (MII-pH) and response to pharmacological anti-reflux therapy were retrospectively reviewed in 38 patients with non-acid GERC and compared with those of 49 patients with acid GERC." | 3.81 | Comparison of clinical characteristics of chronic cough due to non-acid and acid gastroesophageal reflux. ( Chen, Q; Liang, S; Lü, H; Qiu, Z; Xu, X; Yang, Z; Yu, L, 2015) |
| "To evaluate the efficacy and safety of baclofen for treatment of refractory gastroesophageal reflux-induced chronic cough (GERC) unresponsive to standard anti-reflux therapy." | 3.79 | Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough. ( Chen, Q; Liang, SW; Lv, HJ; Qiu, ZM; Xu, XH; Yang, ZM; Yu, L, 2013) |
| " We evaluated 34 patients with GERD (24 men and 10 women, aged 21-63) and extraesophageal respiratory symptoms (wheezing and/or cough) before therapy and after a 12-week treatment with double dose of omeprazole." | 3.77 | Patients with gastroesophageal reflux disease and respiratory manifestations do not present lung function disorders during cardiopulmonary exercise test. ( Giannikoulis, C; Karkoulias, K; Marangos, M; Nikolopoulou, V; Spiropoulos, K; Thomopoulos, K, 2011) |
| "The number of coughs elicited by capsaicin was significantly increased 24 h after challenge with OVA compared with saline, indicating antigen-induced increase in cough reflex sensitivity." | 3.73 | Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs. ( Fujimura, M; Hara, J; Katayama, N; Kita, T; Myou, S; Nakao, S; Nishitsuji, M; Oribe, Y, 2005) |
| "To report a case of chronic, persistent cough induced by omeprazole therapy." | 3.72 | Omeprazole-induced intractable cough. ( Delafosse, C; Howaizi, M, 2003) |
| "Empiric omeprazole therapy is a reasonable, initial approach to patients with suspected gastroesophageal reflux-related posterior laryngitis." | 3.69 | Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study. ( Delgaudio, JM; Grist, WJ; Gussack, G; Waring, JP; Wo, JM, 1997) |
| " Secondary end-points were the rate of control of chronic cough at each step of therapy, the duration of treatment required, changes in cough symptom score, health-related quality of life and possible adverse effects." | 2.75 | Efficacy and safety of modified sequential three-step empirical therapy for chronic cough. ( Li, X; Liang, S; Liu, B; Lü, H; Qiu, Z; Wang, L; Wang, Y; Wei, W; Yu, L, 2010) |
| "Twenty-three patients were evaluated for gastroesophageal reflux disease; six (26%) were eventually determined to have an acid-related cough." | 2.69 | A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough. ( Kavuru, MS; Ours, TM; Richter, JE; Schilz, RJ, 1999) |
| "Twenty-one patients completed both treatment periods." | 2.69 | Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole. ( Hietanen, EK; Kiljander, TO; Salomaa, ER; Terho, EO, 2000) |
| "Gastroesophageal reflux disease (GERD) often presents as typical symptoms such as heartburn or acid regurgitation." | 2.44 | [Extraesophageal manifestations of gastroesophageal reflux disease]. ( Kim, GH, 2008) |
| "Gastroesophageal reflux disease (GERD) is a common condition that effects about 10% of the adult population comprising a broad spectrum of symptoms and varying degrees of severity and frequency." | 2.42 | Extra-esophageal disorders in gastroesophageal reflux disease. ( Jaspersen, D, 2004) |
| "Both GERD(gastroesophageal reflux disease) and chronic respiratory disease are common disease in old and the association between GERD and chronic respiratory disease are recently proved in many reports." | 2.41 | [Chronic respiratory disease and gastroesophageal reflux]. ( Dobashi, K, 2002) |
| "Gastroesophageal reflux disease (GERD) causes chronic cough and triggers asthma." | 2.41 | Chronic cough, asthma, and gastroesophageal reflux. ( Harding, SM; Lazenby, JP, 2000) |
| "Gastroesophageal reflux disease (GERD) can present with both typical symptoms such as heartburn and regurgitation as well as atypical symptoms." | 2.41 | Gastroesophageal reflux disease: extraesophageal manifestations and therapy. ( DeVault, KR, 2001) |
| "Gastroesophageal reflux disease (GERD) is recognized to be present in 10-20% of cases of chronic cough." | 2.39 | Excluding gastroesophageal reflux disease as the cause of chronic cough. ( Castell, DO; Gideon, RM; Johnston, BT, 1996) |
| "The correlation between gastroesophageal reflux and several related variables was evaluated." | 1.35 | Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease. ( Cerci, SS; Oztürk, O; Sahin, U; Senol, A; Songür, N; Songür, Y; Yarktaş, MH, 2008) |
| "Cough was significantly less severe in NEE adolescents than in younger children." | 1.33 | Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients. ( Amer, F; Chiu, YL; Gupta, SK; Hassall, E; Heyman, MB, 2006) |
| "The cough was eliminated or markedly improved in 38 patients (86%) after 4 weeks and by 8 weeks in the remaining 6 patients." | 1.32 | Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment. ( Kallay, MC; Poe, RH, 2003) |
| "Reflux-cough is a diagnosis based on demonstrating both gastro-oesophageal reflux and a positive response to anti-reflux therapy." | 1.32 | Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough". ( Heaney, LG; Johnston, BT; MacMahon, J; McGarvey, LP; Patterson, RN, 2004) |
| "The association between GERD and these supraesophageal symptoms may be elusive." | 1.30 | Supraesophageal manifestations of gastroesophageal reflux disease. ( Al-Sabbagh, G; Wo, JM, 1999) |
| "Although gastro-esophageal reflux (GER) is one of the major causes of chronic persistent cough (CPC) in the USA and in Europe, it is a rare cause of CPC in Japan." | 1.29 | [A case of chronic persistent cough caused by gastro-esophageal reflux]. ( Amemiya, T; Fujimura, M; Matsuda, T; Mizuguchi, M; Nishi, K; Ooka, T, 1995) |
| "Gastroesophageal reflux may be responsible for atypical symptoms such as chronic cough and hoarseness." | 1.29 | Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease. Diagnosis and response to therapy. ( Hunter, J; Katz, E; Lacayo, L; Suwak, B; Waring, JP, 1995) |
| "Respiratory complications of gastroesophageal reflux disease that have been reported include hoarseness, wheezing, bronchospasm, stridor, laryngitis, and chronic cough." | 1.29 | Gastroesophageal reflux-induced cough syncope. ( Puetz, TR; Vakil, N, 1995) |
| "Documenting abnormal gastroesophageal reflux helps direct appropriate therapy, and proximal pH monitoring may identify patients with pulmonary symptoms who respond to anti-reflux therapy." | 1.29 | Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy. ( Castell, DO; Castell, JA; Schnatz, PF, 1996) |
| "Presentation of 7 cases of Gastro-oesophageal Reflux (GOR) detected through the respiratory symptomatology which they manifested." | 1.28 | [Respiratory manifestations and gastroesophageal reflux]. ( Cabratosa, J; Cordón, F; Gómez, F; Jaumá, R; Payola, N, 1992) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 12 (30.00) | 18.2507 |
| 2000's | 18 (45.00) | 29.6817 |
| 2010's | 10 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dutta, P | 1 |
| Funston, W | 1 |
| Mossop, H | 1 |
| Ryan, V | 1 |
| Jones, R | 1 |
| Forbes, R | 1 |
| Sen, S | 1 |
| Pearson, J | 1 |
| Griffin, SM | 1 |
| Smith, JA | 1 |
| Ward, C | 1 |
| Forrest, IA | 1 |
| Simpson, AJ | 1 |
| Xu, XH | 1 |
| Yang, ZM | 1 |
| Chen, Q | 2 |
| Yu, L | 3 |
| Liang, SW | 1 |
| Lv, HJ | 1 |
| Qiu, ZM | 1 |
| Xu, X | 1 |
| Yang, Z | 1 |
| Liang, S | 2 |
| Lü, H | 2 |
| Qiu, Z | 3 |
| Yadlapati, R | 1 |
| Pandolfino, JE | 1 |
| Lidder, AK | 1 |
| Shabeeb, N | 1 |
| Jaiyeola, DM | 1 |
| Adkins, C | 1 |
| Agrawal, N | 1 |
| Cooper, A | 1 |
| Price, CP | 1 |
| Ciolino, JD | 1 |
| Gawron, AJ | 1 |
| Smith, SS | 1 |
| Bove, M | 1 |
| Tan, BK | 1 |
| Songür, N | 1 |
| Songür, Y | 1 |
| Cerci, SS | 1 |
| Oztürk, O | 1 |
| Sahin, U | 1 |
| Senol, A | 1 |
| Yarktaş, MH | 1 |
| Kim, GH | 1 |
| Reiche, I | 1 |
| Tröger, U | 1 |
| Martens-Lobenhoffer, J | 1 |
| Kandulski, A | 1 |
| Neumann, H | 1 |
| Malfertheiner, P | 1 |
| Bode-Böger, SM | 1 |
| Wei, W | 1 |
| Wang, Y | 1 |
| Li, X | 1 |
| Wang, L | 1 |
| Liu, B | 1 |
| Giannikoulis, C | 1 |
| Karkoulias, K | 1 |
| Thomopoulos, K | 1 |
| Marangos, M | 1 |
| Spiropoulos, K | 1 |
| Nikolopoulou, V | 1 |
| Sana, S | 1 |
| Sana, M | 1 |
| Johnston, N | 1 |
| Mittal, SK | 1 |
| Gladu, RH | 1 |
| Hawkins, CA | 1 |
| Adamko, DJ | 1 |
| Majaesic, CM | 1 |
| Skappak, C | 1 |
| Jones, AB | 1 |
| Dobashi, K | 1 |
| Wepner, U | 1 |
| Poe, RH | 1 |
| Kallay, MC | 1 |
| Howaizi, M | 1 |
| Delafosse, C | 1 |
| Jaspersen, D | 2 |
| Patterson, RN | 1 |
| Johnston, BT | 2 |
| MacMahon, J | 1 |
| Heaney, LG | 1 |
| McGarvey, LP | 1 |
| Sawabata, N | 1 |
| Maeda, H | 1 |
| Takeda, S | 1 |
| Inoue, M | 1 |
| Koma, M | 1 |
| Tokunaga, T | 1 |
| Matsuda, H | 1 |
| Chung, KF | 1 |
| Oribe, Y | 1 |
| Fujimura, M | 2 |
| Kita, T | 1 |
| Katayama, N | 1 |
| Nishitsuji, M | 1 |
| Hara, J | 1 |
| Myou, S | 1 |
| Nakao, S | 1 |
| Baldi, F | 1 |
| Cappiello, R | 1 |
| Cavoli, C | 1 |
| Ghersi, S | 1 |
| Torresan, F | 1 |
| Roda, E | 1 |
| Silvers, WS | 1 |
| Levine, JS | 1 |
| Poole, JA | 1 |
| Naar, E | 1 |
| Weber, RW | 1 |
| Gupta, SK | 1 |
| Hassall, E | 1 |
| Chiu, YL | 1 |
| Amer, F | 1 |
| Heyman, MB | 1 |
| Nishi, K | 1 |
| Amemiya, T | 1 |
| Mizuguchi, M | 1 |
| Ooka, T | 1 |
| Matsuda, T | 1 |
| Waring, JP | 2 |
| Lacayo, L | 1 |
| Hunter, J | 1 |
| Katz, E | 1 |
| Suwak, B | 1 |
| Tibbling, L | 1 |
| Puetz, TR | 1 |
| Vakil, N | 1 |
| Gideon, RM | 1 |
| Castell, DO | 2 |
| Schnatz, PF | 1 |
| Castell, JA | 1 |
| Wo, JM | 2 |
| Grist, WJ | 1 |
| Gussack, G | 1 |
| Delgaudio, JM | 1 |
| Al-Sabbagh, G | 1 |
| Diehl, KL | 1 |
| Geyer, P | 1 |
| Martens, E | 1 |
| Irwin, RS | 1 |
| Zawacki, JK | 1 |
| Ours, TM | 1 |
| Kavuru, MS | 1 |
| Schilz, RJ | 1 |
| Richter, JE | 1 |
| Lazenby, JP | 1 |
| Harding, SM | 1 |
| Kiljander, TO | 1 |
| Salomaa, ER | 1 |
| Hietanen, EK | 1 |
| Terho, EO | 1 |
| DeVault, KR | 1 |
| Jaumá, R | 1 |
| Payola, N | 1 |
| Gómez, F | 1 |
| Cordón, F | 1 |
| Cabratosa, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Clinical Application of Vagus Nerve Preservation in Minimally Invasive Surgery for Early Lung Cancer[NCT04125979] | 120 participants (Anticipated) | Interventional | 2019-01-01 | Recruiting | |||
| Prospective Randomized Controlled Study on the Effects of Vagus Nerve Pulmonary Branch Preservation During Video-assisted Thoracic Surgery Lobectomy in Non-small Cell Lung Cancer: Can it Decrease Postoperative Cough and Pulmonary Complications[NCT04923412] | 214 participants (Anticipated) | Interventional | 2021-07-01 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 reviews available for omeprazole and Cough
| Article | Year |
|---|---|
[Extraesophageal manifestations of gastroesophageal reflux disease].
Topics: Anti-Ulcer Agents; Asthma; Cough; Esophageal pH Monitoring; Gastric Acidity Determination; Gastroeso | 2008 |
[Chronic respiratory disease and gastroesophageal reflux].
Topics: Asthma; Chronic Disease; Cough; Diet Therapy; Gastroesophageal Reflux; Histamine H2 Antagonists; Hum | 2002 |
Extra-esophageal disorders in gastroesophageal reflux disease.
Topics: Asthma; Cough; Enzyme Inhibitors; Gastroesophageal Reflux; Humans; Laryngitis; Omeprazole; Proton Pu | 2004 |
Excluding gastroesophageal reflux disease as the cause of chronic cough.
Topics: Anti-Ulcer Agents; Chronic Disease; Cough; Female; Gastroesophageal Reflux; Humans; Middle Aged; Ome | 1996 |
Chronic cough, asthma, and gastroesophageal reflux.
Topics: Anti-Ulcer Agents; Asthma; Chronic Disease; Cough; Gastroesophageal Reflux; Humans; Hydrogen-Ion Con | 2000 |
Gastroesophageal reflux disease: extraesophageal manifestations and therapy.
Topics: Aged; Aged, 80 and over; Anti-Ulcer Agents; Asthma; Cough; Female; Fundoplication; Gastroesophageal | 2001 |
6 trials available for omeprazole and Cough
| Article | Year |
|---|---|
Randomised, double-blind, placebo-controlled pilot trial of omeprazole in idiopathic pulmonary fibrosis.
Topics: Adult; Aged; Aged, 80 and over; Cough; Double-Blind Method; Feasibility Studies; Female; Forced Expi | 2019 |
Efficacy and safety of modified sequential three-step empirical therapy for chronic cough.
Topics: Adult; Aminophylline; Antitussive Agents; Budesonide; Cetirizine; Chlorpheniramine; Chronic Disease; | 2010 |
[A pilot trial on the treatment of gastroesophageal reflux-related cough in infants].
Topics: Bethanechol; Cough; Double-Blind Method; Female; Gastroesophageal Reflux; Humans; Hydrogen-Ion Conce | 2012 |
Proton pump inhibitor treatment of patients with gastroesophageal reflux-related chronic cough: a comparison between two different daily doses of lansoprazole.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Anti-Ulcer Agents; Chronic Disease; Cough; Enz | 2006 |
A prospective evaluation of esophageal testing and a double-blind, randomized study of omeprazole in a diagnostic and therapeutic algorithm for chronic cough.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Algorithms; Chronic Disease; Cough; Double-Blind Method; | 1999 |
Chronic cough and gastro-oesophageal reflux: a double-blind placebo-controlled study with omeprazole.
Topics: Adult; Aged; Anti-Ulcer Agents; Cough; Cross-Over Studies; Double-Blind Method; Female; Gastroesopha | 2000 |
28 other studies available for omeprazole and Cough
| Article | Year |
|---|---|
Therapeutic efficacy of baclofen in refractory gastroesophageal reflux-induced chronic cough.
Topics: Adult; Baclofen; Capsaicin; Cohort Studies; Cough; Domperidone; Esophageal pH Monitoring; Female; Ga | 2013 |
Comparison of clinical characteristics of chronic cough due to non-acid and acid gastroesophageal reflux.
Topics: Adult; Anti-Ulcer Agents; Baclofen; Capsaicin; Chronic Disease; Cough; Domperidone; Esophageal pH Mo | 2015 |
Oropharyngeal pH Testing Does Not Predict Response to Proton Pump Inhibitor Therapy in Patients with Laryngeal Symptoms.
Topics: Adult; Chronic Disease; Cohort Studies; Cough; Deglutition Disorders; Female; Hoarseness; Humans; Hy | 2016 |
Gastroesophageal scintigraphy in the evaluation of adult patients with chronic cough due to gastroesophageal reflux disease.
Topics: Adult; Aged; Case-Control Studies; Chronic Disease; Cough; Esophagitis, Peptic; Esophagus; Female; G | 2008 |
Omeprazole-induced cough in a patient with gastroesophageal reflux disease.
Topics: Aged; Cough; Female; Gastroesophageal Reflux; Humans; Omeprazole; Proton Pump Inhibitors | 2010 |
Patients with gastroesophageal reflux disease and respiratory manifestations do not present lung function disorders during cardiopulmonary exercise test.
Topics: Adult; Anti-Ulcer Agents; Cough; Exercise Test; Female; Gastroesophageal Reflux; Gastroscopy; Heart | 2011 |
Hoarseness and chronic cough: would you suspect reflux?
Topics: Adult; Chronic Disease; Cough; Diagnosis, Differential; Drug Therapy, Combination; Female; Fundoplic | 2011 |
Combatting the cough that won't quit.
Topics: Algorithms; Anti-Ulcer Agents; Chronic Disease; Cough; Diagnosis, Differential; Family Practice; Fem | 2012 |
[A case for proton pump blocker... When cough comes from the stomach].
Topics: Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antirheumatic Age | 2002 |
Chronic cough and gastroesophageal reflux disease: experience with specific therapy for diagnosis and treatment.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Aged; Aged, 80 and over; Chronic Disease; Cisapride; | 2003 |
Omeprazole-induced intractable cough.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Cough; Female; Heartburn; Humans; Omeprazole | 2003 |
Oesophageal pH monitoring is of limited value in the diagnosis of "reflux-cough".
Topics: Anti-Ulcer Agents; Cough; Esophagus; Follow-Up Studies; Gastroesophageal Reflux; Humans; Hydrogen-Io | 2004 |
[Attention! Cough, asthma and Co. are often caused by reflux].
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adult; Anti-Ulcer Agents; Asthma; Benzimidazoles; Clinical | 2004 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
Persistent cough following pulmonary resection: observational and empiric study of possible causes.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Aged; Benzamides; Carcinoma, Non-Small-Cell Lung; Chronic D | 2005 |
H+/K+-ATPase (proton pump) inhibitors dampen increased cough reflex: more than gastric acid suppression.
Topics: Anti-Ulcer Agents; Cough; Depression, Chemical; Gastric Acid; Gastroesophageal Reflux; Humans; Omepr | 2005 |
Attenuating effect of H+K+ATPase inhibitors on airway cough hypersensitivity induced by allergic airway inflammation in guinea-pigs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Allergens; Animals; Benzimidazoles; Bronchi; Bronchoalveola | 2005 |
Inlet patch of gastric mucosa in upper esophagus causing chronic cough and vocal cord dysfunction.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Androstadienes; Anti-Allergic Agents; Cough; Endoscopy, Gas | 2006 |
Presenting symptoms of nonerosive and erosive esophagitis in pediatric patients.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Abdominal Pain; Adolescent; Anorexia; Anti-Ulcer Agents; Ch | 2006 |
[A case of chronic persistent cough caused by gastro-esophageal reflux].
Topics: Aged; Chronic Disease; Cimetidine; Cough; Female; Gastroesophageal Reflux; Histamine H2 Antagonists; | 1995 |
Chronic cough and hoarseness in patients with severe gastroesophageal reflux disease. Diagnosis and response to therapy.
Topics: Case-Control Studies; Chronic Disease; Cough; Female; Fundoplication; Gastroesophageal Reflux; Heart | 1995 |
Wrong-way swallowing as a possible cause of bronchitis in patients with gastroesophageal reflux disease.
Topics: Bronchitis; Chronic Disease; Cough; Deglutition Disorders; Female; Gastroesophageal Reflux; Hernia, | 1993 |
Gastroesophageal reflux-induced cough syncope.
Topics: Adult; Cisapride; Cough; Drug Therapy, Combination; Gastroesophageal Reflux; Humans; Male; Monitorin | 1995 |
Pulmonary symptoms associated with gastroesophageal reflux: use of ambulatory pH monitoring to diagnose and to direct therapy.
Topics: Anti-Ulcer Agents; Asthma; Cough; Esophagus; Female; Gastroesophageal Reflux; Histamine H2 Antagonis | 1996 |
Empiric trial of high-dose omeprazole in patients with posterior laryngitis: a prospective study.
Topics: Anti-Ulcer Agents; Cough; Deglutition Disorders; Female; Follow-Up Studies; Gastroesophageal Reflux; | 1997 |
Supraesophageal manifestations of gastroesophageal reflux disease.
Topics: Adult; Anti-Ulcer Agents; Cough; Domperidone; Dopamine Antagonists; Endoscopy, Gastrointestinal; Fem | 1999 |
[Diagnostic omeprazole test in suspected reflux-associated chronic cough].
Topics: Adult; Aged; Cough; Diagnosis, Differential; Enzyme Inhibitors; Esophagitis; Female; Gastroesophagea | 1999 |
Accurately diagnosing and successfully treating chronic cough due to gastroesophageal reflux disease can be difficult.
Topics: Antacids; Asthma; Chronic Disease; Consensus Development Conferences as Topic; Cough; Diagnosis, Dif | 1999 |
[Respiratory manifestations and gastroesophageal reflux].
Topics: Adult; Aged; Antacids; Cough; Diet; Female; Gastroesophageal Reflux; Humans; Male; Middle Aged; Omep | 1992 |